Association of DLG5 R30Q variant with inflammatory bowel disease

Mark J. Daly, Alexandra V. Pearce, Lisa Farwell, Sheila A. Fisher, Anna Latiano, Natalie J. Prescott, Alastair Forbes, John Mansfield, Jeremy Sanderson, Diane Langelier, Albert Cohen, Alain Bitton, Gary Wild, Cathryn M. Lewis, Vito Annese, Christopher G. Mathew, John D. Rioux

Research output: Contribution to journalArticlepeer-review


Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory diseases of the gastrointestinal system known as the inflammatory bowel diseases (IBD). Recently, Stoll and colleagues reported a novel finding of genetic variation in the DLG5 gene that is associated with IBD (CD and UC combined). We present here a study of the genetic variation described in that report in two well-powered independent case-control cohorts and one family-based collection, and confirm the proposed association between IBD and the R30Q variant of DLG5 in two of the three studies. We are, however, unable to replicate the other proposed association to the common haplotype described in Stoll et al and suggest that this other finding could conceivably have been partially a statistical fluctuation and partially a result of LD with the replicated R30Q association. This study provides support for the hypothesis that DLG5 constitutes a true IBD risk factor of modest effect.

Original languageEnglish
Pages (from-to)835-839
Number of pages5
JournalEuropean Journal of Human Genetics
Issue number7
Publication statusPublished - Jul 2005


  • Association
  • DLG5
  • IBD
  • R30Q

ASJC Scopus subject areas

  • Genetics(clinical)


Dive into the research topics of 'Association of DLG5 R30Q variant with inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this